Gene · 2114
Papers2,490
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,490
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance. | JCO Precis Oncol | 2022 | 35952322 | PubTator, text mining | PubMed |
| Pyroptotic Patterns in Blood Leukocytes Predict Disease Severity and Outcome in COVID-19 Patients. | Front Immunol | 2022 | 35928821 | PubTator, text mining | PubMed |
| Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy. | Front Mol Biosci | 2022 | 35911954 | PubTator, text mining | PubMed |
| Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer Analysis. | Front Bioeng Biotechnol | 2022 | 35910024 | PubTator, text mining | PubMed |
| The accumulation of copper in the brain of Down syndrome promotes oxidative stress: possible mechanism underlying cognitive impairment. | J Clin Biochem Nutr | 2022 | 35903608 | PubTator, text mining | PubMed |
| Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer. | EBioMedicine | 2022 | 35901658 | PubTator, text mining | PubMed |
| EGFR signaling activates intestinal stem cells by promoting mitochondrial biogenesis and β-oxidation. | Curr Biol | 2022 | 35896119 | PubTator, text mining | PubMed |
| Endothelial Loss of ETS1 Impairs Coronary Vascular Development and Leads to Ventricular Non-Compaction. | Circ Res | 2022 | 35894043 | PubTator, text mining | PubMed |
| Transcriptional and Translational Dynamics of Zika and Dengue Virus Infection. | Viruses | 2022 | 35891396 | PubTator, text mining | PubMed |
| Analysis of Melanoma Gene Expression Signatures at the Single-Cell Level Uncovers 45-Gene Signature Related to Prognosis. | Biomedicines | 2022 | 35884783 | PubTator, text mining | PubMed |
| Emerging Role of Deubiquitinating Enzymes (DUBs) in Melanoma Pathogenesis. | Cancers (Basel) | 2022 | 35884430 | PubTator, text mining | PubMed |
| Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression. | Cells | 2022 | 35883598 | PubTator, text mining | PubMed |
| LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma. | Front Public Health | 2022 | 35874989 | PubTator, text mining | PubMed |
| Recent progress of interferon-tau research and potential direction beyond pregnancy recognition. | J Reprod Dev | 2022 | 35871572 | PubTator, text mining | PubMed |
| Etv2 regulates enhancer chromatin status to initiate Shh expression in the limb bud. | Nat Commun | 2022 | 35864091 | PubTator, text mining | PubMed |
| Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia. | Blood Cancer Discov | 2022 | 35839275 | PubTator, text mining | PubMed |
| A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma. | Biol Proced Online | 2022 | 35836132 | PubTator, text mining | PubMed |
| Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features. | Nat Commun | 2022 | 35817764 | PubTator, text mining | PubMed |
| Potential multi-modal effects of provirus integration on HIV-1 persistence: lessons from other viruses. | Trends Immunol | 2022 | 35817699 | PubTator, text mining | PubMed |
| Leukemic Stem Cell: A Mini-Review on Clinical Perspectives. | Front Oncol | 2022 | 35814466 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2114/papers?page=20